PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Commends SciBase for its Technology Innovation in Detection of Malignant Melanoma - Unique EIS technology supports early, pain-free and reliable detection of malignant melanoma
Frost & Sullivan Commends SciBase for its Technology Innovation in Detection of Malignant Melanoma

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/08/24 - Unique EIS technology supports early, pain-free and reliable detection of malignant melanoma.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The 2011 Frost & Sullivan Europe Technology Innovation Award in Skin Cancer Diagnosis is conferred on SciBase AB for pioneering the development of a unique electrical impedance spectroscopy (EIS) technology for the detection of malignant melanoma.

"SciBase's skin cancer diagnostic platform based on EIS technology, successfully meets the market need for a reliable, fast, portable and accurate decision support tool for objective evaluation of suspicious lesions," notes Frost & Sullivan Research Analyst Sangeetha Prabakar. "The device's unique design and its advanced signal processing capabilities make it a highly desirable system for the early detection of multiple forms of skin cancers."

It measures the overall resistance within the skin tissue on applying alternating currents of varying frequencies. The CE marked device comprises a handheld probe connected to a small device that provides results on screen. The device measures EIS by applying a weak, alternating electrical current between the electrodes on the probe's tip and gives immediate results within a few seconds.

The device uses microinvasive electrodes which provide direct access to the epidermal layer where melanoma starts. A key feature is a classifier that has been trained to interpret the resistance and detect characteristics that relate to malignancies. Another unique feature relates to the use of frequencies that are of clinical relevance to skin.

"The length of the spikes has been carefully chosen so that they do not hit the dermal layer, due to which there is no pain," adds Prabakar. "Moreover, the electrodes are disposable, which eliminates the risk of infection."

The device is currently being studied in clinical trials and results show that the device allows the differential diagnosis of benign and malignant moles with a sensitivity exceeding 98% and specificity over 20 percentage points better than study dermatologists.

"In addition, the device also has been shown to distinguish other types of non-melanoma skin cancer from benign moles with close to 100% sensitivity and 87% specificity," remarks Prabakar. "Such accuracy highlights the clinical significance of SciBase's EIS method."

By allowing physicians to rule out benign lesions and scientifically evaluate suspicious lesions prior to excision, the portable device significantly reduces the time and money spent on unnecessary excisions. Moreover, SciBase technology detects skin cancer rapidly and does not require any invasive procedures.

In addition, the technology's reliance on electrical impedance, one of the most important physical properties of tissues, makes it a potentially useful technique for monitoring alterations.

"For physicians, it enables a faster and efficient diagnosis and decision making," concludes Prabakar. "For patients, it provides procedural convenience and cost savings, due to the reduced requirement of biopsies and surgical procedures."

The Technology Innovation Award is presented to the company that has excelled in the following criteria: uniqueness of technology, impact on new products/applications, impact on functionality, impact on customer value and relevance of innovation to industry.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About SciBase AB

SciBase AB is a privately held Swedish medical technology company, founded in 1998. SciBase has developed a unique patented method based on Electrical Impedance Spectroscopy (EIS). The novel technology is the result of years of academic research at Karolinska Institutet, Sweden. The company is applying its platform technology initially for early detection of deadliest skin cancer form – malignant melanoma, with future scope to extend it to other cancer types. Final product development is completed with clinical trial training study finalized and pivotal verification study ongoing in Europe and US. The company's goal is to commence market introduction in Europe and file for PMA in the US during 2Q12. SciBase has recently won VC funding of SEK 92 million ($13million), which will allow the firm to successfully complete the ongoing final clinical verification process and proceed towards commercialization in Europe/Australia.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Commends SciBase for its Technology Innovation in Detection of Malignant Melanoma

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Emily Bailey 
+44 (0)20 7915 7869 emily.bailey[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)